Ativan Tapering Guide
lorazepam
Boxed Warning
Concomitant use with opioids may result in profound sedation, respiratory depression, coma, and death. Risks of abuse, misuse, and addiction, which can lead to overdose and death. Physical dependence and life-threatening withdrawal reactions.
Overview
Lorazepam is an intermediate-acting benzodiazepine approved for anxiety disorders and as a pre-anesthetic. It has no active metabolites and is metabolized by glucuronidation, making it preferred in patients with hepatic impairment or in the elderly.
0.5mg, 1mg, 2mg
Tablets: 0.5mg, 1mg, 2mg; Oral concentrate: 2mg/mL; Injection: 2mg/mL, 4mg/mL
Category D (positive evidence of risk)
Mechanism of Action
Positive allosteric modulator at GABA-A receptors. Binds to the benzodiazepine site and enhances GABA-mediated chloride conductance, producing anxiolytic, sedative, hypnotic, anticonvulsant, and muscle relaxant effects.
Taper Notes
Medium half-life benzo. Crossover to diazepam often recommended for smoother taper. Liquid formulation available.
Hyperbolic Tapering Guidance
Ashton Manual recommends crossover to diazepam for gradual taper. Never stop abruptly — seizure risk.
Summary written by TaperCommunity, informed by the Maudsley Deprescribing Guidelines (Horowitz & Taylor) and related literature — see Sources & References below. Not affiliated with or endorsed by the Maudsley.
Tapering Protocol
Evidence-based phased reduction schedule. Always taper under medical supervision.
| Phase | Duration | Notes |
|---|---|---|
| Crossover to diazepam (optional) | 2-4 weeks | Some prescribers recommend converting to diazepam for a smoother taper, per the Ashton Manual. |
| Initial reductions | 2-4 weeks per step | Small, gradual reductions. Your prescriber may recommend oral concentrate for precision. |
| Middle reductions | 2-4 months | Lorazepam's medium half-life means interdose fluctuations are possible. Your prescriber may split doses for more even coverage. |
| Final reductions | 2-4 months | Oral concentrate allows the most precise adjustments. The final stretch is the most challenging. |
Withdrawal Timeline
12-24 hours after reduction (faster than Klonopin due to shorter half-life)
3-7 days
2-6 weeks for acute symptoms
Anxiety rebound, insomnia, and depersonalization may persist 3-12 months. Shorter half-life than Klonopin means somewhat faster acute resolution but protracted symptoms are similar.
Community Tips
Practical insights shared by members tapering Ativan. Not medical advice — always consult your prescriber.
- 1Ask your prescriber about Ativan oral concentrate — it allows very precise adjustments at lower doses.
- 2Lorazepam has no active metabolites and uses glucuronidation (not CYP enzymes), so it has fewer drug interactions than other benzos — relevant if you're on multiple medications.
- 3Discuss dosing schedule with your prescriber — splitting doses throughout the day can help with interdose symptoms.
- 4Many members find the diazepam crossover worthwhile despite the initial adjustment period. Discuss this option with your prescriber.
Common Withdrawal Symptoms
Interactions & Safety
Drug Interactions
- Opioids — FDA boxed warning: concurrent use increases risk of profound sedation, respiratory depression, coma, and death
- CNS depressants (alcohol, barbiturates, other sedatives) — additive respiratory depression
- Probenecid and valproate may increase lorazepam levels (inhibit glucuronidation)
Food Interactions
- Food may slow absorption rate but does not reduce total bioavailability
- Avoid alcohol (additive CNS and respiratory depression, potentially fatal)
Contraindications
- Acute narrow-angle glaucoma
- Known hypersensitivity to lorazepam or other benzodiazepines
- Intra-arterial injection (parenteral formulation)
Toxicity
CNS and respiratory depression, especially with opioids or alcohol. Physical dependence with chronic use. Abrupt discontinuation can cause seizures, psychosis, and death.
Pharmacokinetics
ADME Profile
Well absorbed after oral administration. Bioavailability ~90%. Tmax ~2 hours. Food may slow absorption but does not reduce bioavailability.
~1.3 L/kg
Hepatic via glucuronidation (UGT) to the inactive lorazepam glucuronide. Does NOT undergo CYP-mediated oxidative metabolism, making it preferred in hepatic impairment.
Renal (~88% as glucuronide conjugate). Less than 1% excreted unchanged in urine.
~85%
~1.1 mL/min/kg
Need a clinician who understands tapering?
Browse our map of deprescribing-informed providers worldwide.
Other Drug Profiles
Sources & References
Ativan (lorazepam) information on this page is sourced from peer-reviewed research, regulatory bodies, clinical guidelines, and patient-advocacy organizations.
Encyclopedic & chemical databases
Neutral, high-authority entity references.
Regulatory sources
Official prescribing information and safety notices.
Peer-reviewed research
Primary literature cited in this taper guide.
- Lader M 2014 — Benzodiazepine harm: how can it be reduced? (British Journal of Clinical Pharmacology)
- Ashton CH 2005 — The diagnosis and management of benzodiazepine dependence (Current Opinion in Psychiatry)
- Horowitz MA, Taylor D 2019 — Tapering of SSRI treatment to mitigate withdrawal symptoms (hyperbolic taper) (The Lancet Psychiatry)
Clinical guidelines
Evidence-based deprescribing and prescribing standards.
Deprescribing-specific resources
Clinician-facing references on tapering protocols.
- Ashton Manual (Prof. C. Heather Ashton) — Definitive clinical reference on benzodiazepine taper protocols
- British National Formulary (BNF) — UK formulary guidance on benzodiazepine prescribing
- Deprescribing.org — benzodiazepine algorithm — Evidence-based benzodiazepine deprescribing algorithm
Patient-advocacy & lived-experience
Long-running communities documenting withdrawal experience.
- BenzoBuddies — peer support forum — Largest peer-support community for benzodiazepine taper and withdrawal
- Benzodiazepine Information Coalition — Non-profit education on benzodiazepine dependence and withdrawal
- Inner Compass Initiative — Withdrawal Project — Peer-led psychiatric drug withdrawal resources
- Surviving Antidepressants — benzo & sleep med forum — Community archive of benzodiazepine taper experiences
TaperCommunity does not provide medical advice. Always consult a qualified prescriber before adjusting psychiatric medication.